跳至主要内容
临床试验/NCT02979327
NCT02979327已完成4 期

Cardiovascular Effects of Adderall in Healthy Adults. A Randomized Clinical Trial.

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Mayo Clinic
入组人数
30
试验地点
1
主要终点
Systolic Blood Pressure

研究概览

简要总结

This study is designed to investigate the cardiovascular response (blood pressure, heart rate, electrocardiographic response and blood vessel reactivity response) to taking Adderall in healthy adults.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults 18 years of age and older
  • Healthy subjects without known cardiovascular disease, thyroid disease or documented mental health illness
  • Subjects who are on no medications
  • Subjects with no prior history of regular amphetamine use, and non-prescription stimulants
  • Exclusion Criteria
  • Subjects with known cardiovascular disease, thyroid disease
  • Subjects with history of psychotic disorders/mental health illness, including but not limited to anxiety, depression, bipolar disorder; history of substance abuse or dependence
  • Subjects currently taking medications
  • Prior history of regular amphetamine use, or non-prescription stimulants
  • Pregnant subjects
  • Known lactose intolerance (due to presence of lactose in the prepared medication)
  • Family history of sudden cardiac death

排除标准

  • 未提供

研究组 & 干预措施

Adderall first, then Placebo

Experimental

Participants will receive an Adderall capsule at the first study visit, then a Placebo capsule at the second study visit.

干预措施: Adderall capsule (Drug)

Adderall first, then Placebo

Experimental

Participants will receive an Adderall capsule at the first study visit, then a Placebo capsule at the second study visit.

干预措施: Placebo capsule (Drug)

Placebo first, then Adderall

Experimental

Participants will receive a Placebo capsule at the first study visit, then an Adderall capsule at the second study visit.

干预措施: Adderall capsule (Drug)

Placebo first, then Adderall

Experimental

Participants will receive a Placebo capsule at the first study visit, then an Adderall capsule at the second study visit.

干预措施: Placebo capsule (Drug)

结局指标

主要结局

Systolic Blood Pressure

时间窗: Baseline and 3 hours

Systolic blood pressure (top number of blood pressure reading)

Heart Rate

时间窗: Baseline and 3 hours

Number of beats per minute

Diastolic Blood Pressure

时间窗: Baseline and 3 hours

Diastolic blood pressure (bottom number of blood pressure reading)

Mean Arterial Pressure (MAP)

时间窗: Baseline and 3 hours

Mean arterial pressure (MAP) is a measure of the average blood pressure in the large arteries. It accounts for the blood flow and resistance. Measured in millimeters of mercury (mmHg)

次要结局

  • Plasma Norepinephrine(baseline and 3 hours)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anna Svatikova

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

Cardiovascular Effects of Adderall in Healthy Adults. | 临床试验